Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):4958–4964. doi: 10.1128/iai.65.12.4958-4964.1997

Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

S Ghaem-Maghami 1, R L Bailey 1, D C Mabey 1, P E Hay 1, O S Mahdi 1, H M Joof 1, H C Whittle 1, M E Ward 1, D J Lewis 1
PMCID: PMC175715  PMID: 9393782

Abstract

The circulating B-cell responses to Chlamydia trachomatis of 60 children and 34 adults in The Gambia were characterized in a cross-sectional study of different grades of trachoma, using the enzyme-linked immunospot (ELISPOT) assay. Antibody-secreting cells (ASCs) specific to chlamydial major outer membrane protein (MOMP), heat shock protein 60, and whole elementary bodies were detected in children with no evidence of ocular disease, and the immunoglobulin (IgA) response was significantly increased in those with follicular trachoma. In marked contrast, children with the most intense ocular inflammation paradoxically had an almost completely absent B-cell response of all isotypes and to all chlamydial antigens, but with normal serum IgG and IgA responses, which was even lower than in the group with no ocular inflammation. Adults with or without evidence of trachomatous scarring had equivalent numbers of circulating B cells, principally IgA, to all chlamydial antigens. Plasmablasts secreting antibodies to MOMP were present in the urine of children in the absence of urogenital infection detectable by PCR, and relative numbers were 8 to 25 times higher than in blood, suggesting site-specific homing within a common mucosal immune system. These results suggest that ELISPOT assay of ongoing B-cell responses detects suppression of chlamydia-specific IgA ASCs during the proinflammatory response to ocular chlamydial infection seen in intense trachoma, which may play a role in tissue damage leading to trachomatous scarring.

Full Text

The Full Text of this article is available as a PDF (164.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey R. L., Hampton T. J., Hayes L. J., Ward M. E., Whittle H. C., Mabey D. C. Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. J Infect Dis. 1994 Sep;170(3):709–712. doi: 10.1093/infdis/170.3.709. [DOI] [PubMed] [Google Scholar]
  2. Bailey R. L., Hayes L., Pickett M., Whittle H. C., Ward M. E., Mabey D. C. Molecular epidemiology of trachoma in a Gambian village. Br J Ophthalmol. 1994 Nov;78(11):813–817. doi: 10.1136/bjo.78.11.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailey R. L., Holland M. J., Whittle H. C., Mabey D. C. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun. 1995 Feb;63(2):389–392. doi: 10.1128/iai.63.2.389-392.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bailey R. L., Kajbaf M., Whittle H. C., Ward M. E., Mabey D. C. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect. 1993 Oct;111(2):315–324. doi: 10.1017/s0950268800057022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bobo L., Novak N., Mkocha H., Vitale S., West S., Quinn T. C. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun. 1996 Aug;64(8):3273–3279. doi: 10.1128/iai.64.8.3273-3279.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brunham R. C., Kuo C. C., Cles L., Holmes K. K. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun. 1983 Mar;39(3):1491–1494. doi: 10.1128/iai.39.3.1491-1494.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brunham R. C., Maclean I. W., Binns B., Peeling R. W. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis. 1985 Dec;152(6):1275–1282. doi: 10.1093/infdis/152.6.1275. [DOI] [PubMed] [Google Scholar]
  8. Brunham R. C., Peeling R. W. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis. 1994 Oct;3(5):218–233. [PubMed] [Google Scholar]
  9. Brunham R. C., Peeling R., Maclean I., Kosseim M. L., Paraskevas M. Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates. J Infect Dis. 1992 Jun;165(6):1076–1081. doi: 10.1093/infdis/165.6.1076. [DOI] [PubMed] [Google Scholar]
  10. Brunham R. C., Peeling R., Maclean I., McDowell J., Persson K., Osser S. Postabortal Chlamydia trachomatis salpingitis: correlating risk with antigen-specific serological responses and with neutralization. J Infect Dis. 1987 Apr;155(4):749–755. doi: 10.1093/infdis/155.4.749. [DOI] [PubMed] [Google Scholar]
  11. Castello-Branco L. R., Griffin G. E., Poulton T. A., Dougan G., Lewis D. J. Characterization of the circulating T-cell response after oral immunization of human volunteers with cholera toxin B subunit. Vaccine. 1994 Jan;12(1):65–72. doi: 10.1016/0264-410x(94)90012-4. [DOI] [PubMed] [Google Scholar]
  12. Cui Z. D., Tristram D., LaScolea L. J., Kwiatkowski T., Jr, Kopti S., Ogra P. L. Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization. Infect Immun. 1991 Apr;59(4):1465–1469. doi: 10.1128/iai.59.4.1465-1469.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Czerkinsky C. C., Nilsson L. A., Nygren H., Ouchterlony O., Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods. 1983 Dec 16;65(1-2):109–121. doi: 10.1016/0022-1759(83)90308-3. [DOI] [PubMed] [Google Scholar]
  14. Czerkinsky C., Svennerholm A. M., Holmgren J. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin Infect Dis. 1993 Mar;16 (Suppl 2):S106–S116. doi: 10.1093/clinids/16.supplement_2.s106. [DOI] [PubMed] [Google Scholar]
  15. Czerkinsky C., Svennerholm A. M., Quiding M., Jonsson R., Holmgren J. Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans. Infect Immun. 1991 Mar;59(3):996–1001. doi: 10.1128/iai.59.3.996-1001.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ford W. L. Lymphocyte migration and immune responses. Prog Allergy. 1975;19:1–59. doi: 10.1159/000313381. [DOI] [PubMed] [Google Scholar]
  17. Hall J. G. An essay on lymphocyte circulation and the gut. Monogr Allergy. 1980;16:100–111. [PubMed] [Google Scholar]
  18. Ho F., Lortan J. E., MacLennan I. C., Khan M. Distinct short-lived and long-lived antibody-producing cell populations. Eur J Immunol. 1986 Oct;16(10):1297–1301. doi: 10.1002/eji.1830161018. [DOI] [PubMed] [Google Scholar]
  19. Holmgren J., Czerkinsky C. Cholera as a model for research on mucosal immunity and development of oral vaccines. Curr Opin Immunol. 1992 Aug;4(4):387–391. doi: 10.1016/s0952-7915(06)80027-0. [DOI] [PubMed] [Google Scholar]
  20. Holt P. G., Sedgwick J. D., Stewart G. A., O'Leary C., Krska K. ELISA plaque assay for the detection of antibody secreting cells: observations on the nature of the solid phase and on variations in plaque diameter. J Immunol Methods. 1984 Nov 16;74(1):1–7. doi: 10.1016/0022-1759(84)90360-0. [DOI] [PubMed] [Google Scholar]
  21. Johansson M., Schön K., Ward M., Lycke N. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun. 1997 Mar;65(3):1032–1044. doi: 10.1128/iai.65.3.1032-1044.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kantele A., Arvilommi H., Jokinen I. Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis. 1986 Jun;153(6):1126–1131. doi: 10.1093/infdis/153.6.1126. [DOI] [PubMed] [Google Scholar]
  23. Lewis D. J., Novotny P., Dougan G., Griffin G. E. The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur J Immunol. 1991 Sep;21(9):2087–2094. doi: 10.1002/eji.1830210917. [DOI] [PubMed] [Google Scholar]
  24. Magee D. M., Williams D. M., Smith J. G., Bleicker C. A., Grubbs B. G., Schachter J., Rank R. G. Role of CD8 T cells in primary Chlamydia infection. Infect Immun. 1995 Feb;63(2):516–521. doi: 10.1128/iai.63.2.516-521.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McDermott M. R., Bienenstock J. Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J Immunol. 1979 May;122(5):1892–1898. [PubMed] [Google Scholar]
  26. Mestecky J. Immunobiology of IgA. Am J Kidney Dis. 1988 Nov;12(5):378–383. doi: 10.1016/s0272-6386(88)80029-5. [DOI] [PubMed] [Google Scholar]
  27. Morrison R. P. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Semin Immunol. 1991 Jan;3(1):25–33. [PubMed] [Google Scholar]
  28. Pal S., Fielder T. J., Peterson E. M., de la Maza L. M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun. 1994 Aug;62(8):3354–3362. doi: 10.1128/iai.62.8.3354-3362.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pal S., Taylor H. R., Huneke R. B., Prendergast R. A., Whittum-Hudson J. A. Frequency of antigen-specific B cells during experimental ocular Chlamydia trachomatis infection. Infect Immun. 1992 Dec;60(12):5294–5297. doi: 10.1128/iai.60.12.5294-5297.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pickett M. A., Ward M. E., Clarke I. N. High-level expression and epitope localization of the major outer membrane protein of Chlamydia trachomatis serovar L1. Mol Microbiol. 1988 Sep;2(5):681–685. doi: 10.1111/j.1365-2958.1988.tb00077.x. [DOI] [PubMed] [Google Scholar]
  31. Quiding-Järbrink M., Lakew M., Nordström I., Banchereau J., Butcher E., Holmgren J., Czerkinsky C. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur J Immunol. 1995 Feb;25(2):322–327. doi: 10.1002/eji.1830250203. [DOI] [PubMed] [Google Scholar]
  32. Rahman M. U., Hudson A. P., Schumacher H. R., Jr Chlamydia and Reiter's syndrome (reactive arthritis). Rheum Dis Clin North Am. 1992 Feb;18(1):67–79. [PubMed] [Google Scholar]
  33. Salmi M., Andrew D. P., Butcher E. C., Jalkanen S. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med. 1995 Jan 1;181(1):137–149. doi: 10.1084/jem.181.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schachter J., Dawson C. R. The epidemiology of trachoma predicts more blindness in the future. Scand J Infect Dis Suppl. 1990;69:55–62. [PubMed] [Google Scholar]
  35. Sedgwick J. D., Holt P. G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods. 1983 Feb 25;57(1-3):301–309. doi: 10.1016/0022-1759(83)90091-1. [DOI] [PubMed] [Google Scholar]
  36. Sowa S., Sowa J., Collier L. H., Blyth W. A. Trachoma vaccine field trials in The Gambia. J Hyg (Lond) 1969 Dec;67(4):699–717. doi: 10.1017/s0022172400042157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sprent J., Tough D. F. Lymphocyte life-span and memory. Science. 1994 Sep 2;265(5177):1395–1400. doi: 10.1126/science.8073282. [DOI] [PubMed] [Google Scholar]
  38. Treharne J. D. The community epidemiology of trachoma. Rev Infect Dis. 1985 Nov-Dec;7(6):760–764. doi: 10.1093/clinids/7.6.760. [DOI] [PubMed] [Google Scholar]
  39. VanCott J. L., Staats H. F., Pascual D. W., Roberts M., Chatfield S. N., Yamamoto M., Coste M., Carter P. B., Kiyono H., McGhee J. R. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol. 1996 Feb 15;156(4):1504–1514. [PubMed] [Google Scholar]
  40. Wang S. P., Grayston J. T., Alexander E. R. Trachoma vaccine studies in monkeys. Am J Ophthalmol. 1967 May;63(5 Suppl):1615–1630. doi: 10.1016/0002-9394(67)94155-4. [DOI] [PubMed] [Google Scholar]
  41. Wang S. P., Grayston J. T. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol. 1967 May;63(5 Suppl):1133–1145. doi: 10.1016/0002-9394(67)94095-0. [DOI] [PubMed] [Google Scholar]
  42. Ward M. E. The immunobiology and immunopathology of chlamydial infections. APMIS. 1995 Nov;103(11):769–796. doi: 10.1111/j.1699-0463.1995.tb01436.x. [DOI] [PubMed] [Google Scholar]
  43. Watson R. R., Mull J. D., MacDonald A. B., Thompson S. E., 3rd, Bear S. E. Immunity to chlamydial infections of the eye. II. Studies of passively transferred serum antibody in resistance to infection with guinea pig inclusion conjunctivitis. Infect Immun. 1973 Apr;7(4):597–599. doi: 10.1128/iai.7.4.597-599.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Williams D. M., Schachter J., Grubbs B. Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun. 1987 Jan;55(1):223–226. doi: 10.1128/iai.55.1.223-226.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES